SE409032B - Forfarande for framstellning av tetrazolylderivat av prostaglandiner - Google Patents

Forfarande for framstellning av tetrazolylderivat av prostaglandiner

Info

Publication number
SE409032B
SE409032B SE7211233A SE1123372A SE409032B SE 409032 B SE409032 B SE 409032B SE 7211233 A SE7211233 A SE 7211233A SE 1123372 A SE1123372 A SE 1123372A SE 409032 B SE409032 B SE 409032B
Authority
SE
Sweden
Prior art keywords
prostaglandins
procedure
preparation
tetrazolyl derivatives
tetrazolyl
Prior art date
Application number
SE7211233A
Other languages
English (en)
Swedish (sv)
Inventor
H-J E Hess
T K Schaaf
L J Czuba
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE409032B publication Critical patent/SE409032B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7211233A 1971-09-01 1972-08-30 Forfarande for framstellning av tetrazolylderivat av prostaglandiner SE409032B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17710271A 1971-09-01 1971-09-01

Publications (1)

Publication Number Publication Date
SE409032B true SE409032B (sv) 1979-07-23

Family

ID=22647201

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7211233A SE409032B (sv) 1971-09-01 1972-08-30 Forfarande for framstellning av tetrazolylderivat av prostaglandiner
SE7606689A SE421525B (sv) 1971-09-01 1976-06-11 Vissa angivna tetrazolderivat till anvendning for framstellning av vissa prostaglandiner
SE7606690A SE421526B (sv) 1971-09-01 1976-06-11 Vissa angivna furanderivat till anvendning for framstellning av vissa prostaglandiner
SE7606691A SE424185B (sv) 1971-09-01 1976-06-11 4-(tetrazol-5-yl)-butyltrifenylfosfoniumbromid, anvendbart vid framstellning av prostaglandinanaloger samt forfarande for framstellning derav

Family Applications After (3)

Application Number Title Priority Date Filing Date
SE7606689A SE421525B (sv) 1971-09-01 1976-06-11 Vissa angivna tetrazolderivat till anvendning for framstellning av vissa prostaglandiner
SE7606690A SE421526B (sv) 1971-09-01 1976-06-11 Vissa angivna furanderivat till anvendning for framstellning av vissa prostaglandiner
SE7606691A SE424185B (sv) 1971-09-01 1976-06-11 4-(tetrazol-5-yl)-butyltrifenylfosfoniumbromid, anvendbart vid framstellning av prostaglandinanaloger samt forfarande for framstellning derav

Country Status (12)

Country Link
JP (1) JPS5724348B2 (de)
AR (4) AR197304A1 (de)
AT (3) AT327219B (de)
CA (1) CA978939A (de)
DK (1) DK144730C (de)
ES (3) ES406250A1 (de)
FI (1) FI55497C (de)
FR (3) FR2283147A1 (de)
IL (3) IL48544A (de)
PH (3) PH10023A (de)
SE (4) SE409032B (de)
ZA (1) ZA725827B (de)

Also Published As

Publication number Publication date
DK144730C (da) 1982-10-18
IL40183A (en) 1977-06-30
AR199574A1 (es) 1974-09-13
SE424185B (sv) 1982-07-05
ES417557A1 (es) 1976-06-16
IL40183A0 (en) 1972-10-29
SE7606691L (sv) 1976-06-11
JPS4834165A (de) 1973-05-16
ES406250A1 (es) 1976-06-01
FR2283136B1 (de) 1978-05-12
AR197304A1 (es) 1974-03-29
PH10443A (en) 1977-03-25
JPS5724348B2 (de) 1982-05-24
IL48544A (en) 1977-06-30
ATA743472A (de) 1976-06-15
ZA725827B (en) 1973-06-27
CA978939A (en) 1975-12-02
FI55497C (fi) 1979-08-10
SE7606690L (sv) 1976-06-11
ES417558A1 (es) 1976-06-16
FR2283147A1 (fr) 1976-03-26
PH10416A (en) 1977-03-16
FI55497B (fi) 1979-04-30
ATA51974A (de) 1975-04-15
AT327219B (de) 1976-01-26
DK144730B (da) 1982-05-24
IL48544A0 (en) 1976-01-30
SE421526B (sv) 1982-01-04
FR2283134A1 (fr) 1976-03-26
AR199573A1 (es) 1974-09-13
FR2283147B1 (de) 1978-05-12
SE421525B (sv) 1982-01-04
FR2283134B1 (de) 1978-05-12
PH10023A (en) 1976-07-13
AT335079B (de) 1977-02-25
AR199784A1 (es) 1974-09-30
FR2283136A1 (fr) 1976-03-26
SE7606689L (sv) 1976-06-11

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE381397B (sv) Forfarande for framstellning av ett aromatiseringsmedel
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE387948B (sv) Forfarande for framstellning av tiofen
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner
SE392724B (sv) Forfarande for framstellning av 7-aminocefalosporansyra
SE387950B (sv) Forfarande for framstellning av diazaborinderivat